Method of treating drug addiction using dextro-morphine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S812000

Reexamination Certificate

active

07943631

ABSTRACT:
The present invention relates a method of treating drug addiction in an individual by administering to the addicted individual a therapeutically effective amount of dextro-morphine capable of activating an opioid receptor. It is disclosed here that dextro-morphine is suitable for treating addiction to natural opiates, semi-synthetic opiates, fully synthetic opioids, and endogenous opioid peptides, as well as nicotine.

REFERENCES:
Horan B, Gardner EL, Dewey SL, Brodie JD, and Ashby CR, “The selective sigma(1) receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (−)-nicotine in rats,” European Journal of Pharmacology, Aug. 2001, 426(1-2), R1-R2.
Maurice T, Casalino M, Lacroix M, and Romieu P, “Involvement of the sigma 1 receptor in the motivational effects of ethanol in mice,” Pharmacoloogy Biochemistry and Behavior, Mar. 2003, 74(4), 869-876.
Romieu P, Phan VL, Martin-Fardon R, and Maurice T, “Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade,” Neuropsychopharmacology, Apr. 2002, 26(4), 444-455.
Stefanski R, Justinova Z, Hayashi T, Takebayashi M, Goldberg SR, and Su TP, “Sigma1 receptor upregulation after chronic methamphetamine self-administration in rats: a study with yoked controls,” Psychopharmacology, Aug. 2004, 175(1), 68-75.
Wu HE, Schwasinger ET, Terashvili M, and Tseng LF, “dextro-Morphine attenuates the morphine-produced conditioned place preference via the sigma(1) receptor activation in the rat,” European Journal of Pharmacology, May 2007, 562(3), 221-226 (Epub Feb. 8, 2007).
Monnet FP, Debonnel G, and de Montigny C, “In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands,” Journal of Pharmacology and Experimental Therapeutics, Apr. 1992, 261(1), 123-130.
Balfour et al.,“The Putative Role of Extra-Synaptic Mesolimbic dopamine in the Neurobiology of Nicotine Dependence,” Behavioural Brain Research (2000) 113:73-83.
Bonci et al., “The Dopamine-containing Neuron: Maestro or Simple Musician in the Orchestra of Addiction?,” TRENDS in Pharmacological Sciences (Apr. 2003) 24(4):172-177.
Contet et al., “Mu Opioid Receptor: A Gateway to Drug Addiction,” Current Opinion in Neurobiology (2004) 14:370-378.
Dani et. al., “Synaptic Plasticity and Nicotine Addiction,” Neuron (2001) 31:349-352.
De Vries, Taco J. and Shippenberg, Toni S., “Neural Systems Underlying Opiate Addiction,” The Journal of Neurosciences (2002) 22(9):3321-3325.
Iijima et al., “Studies in the (+)-Morphinan Series. 4. A Markedly Improved Synthesis of (+)- Morphine,” J. Org. Chem. (1978) 43(7):1462-1463.
Jacquet et al., “Stereospecific and Nonstereospecific Effects of (+)-and (−)- Morphine: Evidence for a New Class of Receptors,” Science (1977) 198:842-845.
Joels, Marian, “Corticosteroid Effects in the Brain: U-shape it,” TRENDS in Pharmacological Sciences (2006) 27 (5):244-250.
McCracken et al., “Two Novel Sigma Receptor Ligands, BD1047 and LR172, Attenuate Cocaine-Induced Toxicity and Locomotor Activity,” European Journal of Pharamacology, (1999) 370:255-232.
Mei, J and Pasternak, G., “Sigma1 Receptor Modulation of Opioid Analgesia in the Mouse,” The Journal of Pharmacology and Experimental Therapeutics (2002) 300(4):1070-1074.
Monnet, Francois and Tangui, Maurice, “The Sigma1 Protein as a Target fot the Non-genomic Effects of Neuro (active)steroids: Molecular, Physiological, and Behavioral Aspects,” Journal of Pharmacological Sciences (2006) 100:93-118.
Mucha, Ronald and Herz, Albert, “Preference Conditioning Produced by Opioid Active and Inactive Isomers of Levorphanol and Morphine in Rat,” Life Science (1986) 38:241-249.
Olmstead, Mary and Burns, Lindsay, “Ultra-low-dose Naltrexone Suppresses Rewarding Effects of Opiates and Aversive Effects of Opiate Withdrawal in Rats,” Psychopharmacology (2005) 181:576-581.
Pilotte, Nancy S., “Neurochemistry of Cocaine Withdrawal,” Current Opinion in Neurology (1997) 10:534-538.
Romieu et al., “Sigma1 Receptor-Related Neuroactive Steroids Modulate Cocaine-Induced Reward,” The Journal of Neuroscience (2003) 23(9):3572-3576.
Shippenberg, Toni and Elmer, Gregory, “The Neurobiology of Opiate Reinforcement,” Critical Reviews in Neurobiology, (1998) 12(4):267-303.
Terashvili et al., “Differential Conditioned Place Preference Responses to Endomorphin-1 and endomorpin-2 Microinjected into the Posterior Nucleus Accumbens Shell and Ventral Tegmental Area in the Rat,” The Journal of Pharmacology and Experimental Therapeutics (2004) 309(2):816-824.
Terashvili et al., “(+)-Morphine and (−)-Morphine Stereoselectively Attenuate the (−)-morphine-produced Tail-flick Inhibition via the Naloxone-sensitive Sigma Receptor in the Ventral Periaqueductal Gray of the Rat,” European Journal of Pharmacology (2007) 571:1-7.
Terashvili et al., “(+)-Morphine attenuates the (−)-Morphine-produced Conditioned Place Preference and the Mu-opioid Receptor-mediated Dopamine Increase in the Posterior Nucleus Accumbens of the Rat,” European Journal of Pharmacology (2008) 587:147-154.
Tsao, Li-i and Su, Tsung-Ping, “Naloxone-Sensitive, Haloperidol-Sensitive, [3H] (+)SKF-10047-Binding Protein Partially Purified From Rate Liver and Rat Brain Membranes: and Opioid/Sigma Receptor,” Synapse (1997) 25:117-124.
Wu et al., “Opposite Conditioned Place Preference Response to Endomorphin-1 and Endomorphin-2 in the Mouse,” Neuroscience Letters (2004) 365:157-161.
Wu et al., “Stereoselective Action of dextro-Morphine over levo-Morphine on Glia in the Mouse Spinal Cord,” The Journal of Pharmacology and Experimental Therapeutics (2005) 314(3):1101-1108.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of treating drug addiction using dextro-morphine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating drug addiction using dextro-morphine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating drug addiction using dextro-morphine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2697571

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.